|
FBXO45 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 6.502200E-01 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.875000E-01 |
| Normal-vs-Stage2 |
5.651000E-01 |
| Normal-vs-Stage3 |
9.963000E-01 |
| Normal-vs-Stage4 |
9.524200E-01 |
| Stage1-vs-Stage2 |
1.901590E-01 |
| Stage1-vs-Stage3 |
3.544800E-01 |
| Stage1-vs-Stage4 |
4.408800E-01 |
| Stage2-vs-Stage3 |
5.651200E-01 |
| Stage2-vs-Stage4 |
6.265000E-01 |
| Stage3-vs-Stage4 |
9.562200E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
5.653200E-01 |
| Normal-vs-AfricanAmerican |
8.222600E-01 |
| Normal-vs-Asian |
4.207600E-01 |
| Caucasian-vs-AfricanAmerican |
9.092600E-01 |
| Caucasian-vs-Asian |
6.438600E-01 |
| AfricanAmerican-vs-Asian |
6.942200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
6.679200E-01 |
| Normal-vs-Female |
4.332400E-01 |
| Male-vs-Female |
1.318150E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.053400E-01 |
| Normal-vs-Age(41-60Yrs) |
6.980600E-01 |
| Normal-vs-Age(61-80Yrs) |
9.500000E-01 |
| Normal-vs-Age(81-100Yrs) |
5.008400E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.412300E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.753790E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
9.628100E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.100800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.807200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.170200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
9.290800E-01 |
| Classical-VS-Follicular |
2.27989999990186E-07 |
| Classical-VS-Other |
9.115600E-02 |
| Classical-VS-Normal |
1.326600E-01 |
| Tall-VS-Follicular |
2.143200E-03 |
| Tall-VS-Other |
1.345630E-01 |
| Tall-VS-Normal |
3.017600E-01 |
| Follicular-VS-Other |
9.660000E-01 |
| Follicular-VS-Normal |
1.299560E-02 |
| Other-VS-Normal |
2.400800E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
7.473800E-01 |
| Normal-vs-N1 |
9.162800E-01 |
| N0-vs-N1 |
8.851600E-01 |
|
|
